Timothy Hoey
Hoofd Techniek/Wetenschap/O&O bij TENAYA THERAPEUTICS, INC.
Vermogen: 1 M $ op 31-05-2024
Actieve functies van Timothy Hoey
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TENAYA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2017 | - |
Loopbaan van Timothy Hoey
Eerdere bekende functies van Timothy Hoey
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 | 01-01-2017 |
| Corporate Officer/Principal | 01-01-2005 | 01-01-2016 | |
| AMGEN INC. | Corporate Officer/Principal | - | 01-01-2005 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Directeur/Bestuurslid | - | 14-12-2011 |
| Corporate Officer/Principal | 14-12-2011 | - |
Opleiding van Timothy Hoey
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Beurs
- Insiders
- Timothy Hoey
- Ervaring
